Your browser doesn't support javascript.
loading
Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies.
Beaton, Laura; Tregidgo, Henry F J; Znati, Sami A; Forsyth, Sharon; Counsell, Nicholas; Clarkson, Matthew J; Bandula, Steven; Chouhan, Manil; Lowe, Helen L; Thin, May Zaw; Hague, Julian; Sharma, Dinesh; Pollok, Joerg-Matthias; Davidson, Brian R; Raja, Jowad; Munneke, Graham; Stuckey, Daniel J; Bascal, Zainab A; Wilde, Paul E; Cooper, Sarah; Ryan, Samantha; Czuczman, Peter; Boucher, Eveline; Hartley, John A; Atkinson, David; Lewis, Andrew L; Jansen, Marnix; Meyer, Tim; Sharma, Ricky A.
Afiliación
  • Beaton L; University College London Cancer Institute, University College London, London, United Kingdom. Electronic address: l.beaton@ucl.ac.uk.
  • Tregidgo HFJ; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
  • Znati SA; University College London Cancer Institute, University College London, London, United Kingdom.
  • Forsyth S; Cancer Research UK and University College London Cancer Trials Centre, University College London, London, United Kingdom.
  • Counsell N; Cancer Research UK and University College London Cancer Trials Centre, University College London, London, United Kingdom.
  • Clarkson MJ; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
  • Bandula S; University College London Centre for Medical Imaging, University College London, London, United Kingdom.
  • Chouhan M; University College London Centre for Medical Imaging, University College London, London, United Kingdom.
  • Lowe HL; University College London Experimental Cancer Medicine Centre Good Clinical Laboratory Practice Facility, University College London, London, United Kingdom.
  • Thin MZ; Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
  • Hague J; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Sharma D; Division of Transplantation and Immunology, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Pollok JM; Division of Surgery and Interventional Science, University College London, London, United Kingdom; Hepatopancreatobiliary Surgery and Liver Transplantation, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Davidson BR; Division of Surgery and Interventional Science, University College London, London, United Kingdom; Hepatopancreatobiliary Surgery and Liver Transplantation, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Raja J; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Munneke G; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Stuckey DJ; Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
  • Bascal ZA; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Wilde PE; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Cooper S; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Ryan S; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Czuczman P; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Boucher E; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Hartley JA; University College London Cancer Institute, University College London, London, United Kingdom; University College London Experimental Cancer Medicine Centre Good Clinical Laboratory Practice Facility, University College London, London, United Kingdom.
  • Atkinson D; University College London Centre for Medical Imaging, University College London, London, United Kingdom.
  • Lewis AL; Biocompatibles UK Ltd, Lakeview, Riverside Way, Watchmoor Park, Camberley, Surrey, United Kingdom.
  • Jansen M; University College London Cancer Institute, University College London, London, United Kingdom; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Meyer T; University College London Cancer Institute, University College London, London, United Kingdom; Department of Oncology, Royal Free Hospital NHS Foundation Trust, London, United Kingdom.
  • Sharma RA; National Institute for Health Research University College London Hospitals Biomedical Centre, University College London Cancer Institute, London, United Kingdom.
J Vasc Interv Radiol ; 33(9): 1034-1044.e29, 2022 09.
Article en En | MEDLINE | ID: mdl-35526675
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Adolescent / Adult / Humans Idioma: En Revista: J Vasc Interv Radiol Asunto de la revista: ANGIOLOGIA / RADIOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Adolescent / Adult / Humans Idioma: En Revista: J Vasc Interv Radiol Asunto de la revista: ANGIOLOGIA / RADIOLOGIA Año: 2022 Tipo del documento: Article